跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ambimox - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ambimox
Approved
STANDARD
Ambimox
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a2c19c01f8720bab
Company
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Type
Standard
Approval Details
Approval Id
a2c19c01f8720bab
Drug Approval Philippines Name
Ambimox
Product Name
Ambimox
Registration Number
DRP-9966
Brand Name
Ambimox
Generic Name
Amoxicillin (as Trihydrate)
Dosage Form
Capsule
Dosage Strength
500 mg
Manufacturer
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Importer
AMB HK Enterprises Inc.
Distributor
AMB HK Enterprises Inc.
Company Detail Path
/organization/cspc-zhongnuo-pharmaceutical-shijiazhuang-co-ltd
Issuance Date
28 November 2023
Expiry Date
08 February 2029
Pharmacologic Category
Antibacterial (Penicillin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a2c19c01f8720bab
Type
Standard
Back to Philippines FDA Approvals